47 filings
8-K
AERI
Aerie Pharmaceuticals Inc
13 Dec 19
Regulation FD Disclosure
6:31am
8-K
AERI
Aerie Pharmaceuticals Inc
3 Dec 19
Regulation FD Disclosure
6:31am
8-K
AERI
Aerie Pharmaceuticals Inc
3 Dec 19
Regulation FD Disclosure
6:30am
8-K
AERI
Aerie Pharmaceuticals Inc
21 Nov 19
Regulation FD Disclosure
6:41am
8-K
AERI
Aerie Pharmaceuticals Inc
18 Nov 19
Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma, S.L. to Advance its Dry Eye Program
6:41am
8-K
v0expx xikk63
18 Nov 19
Regulation FD Disclosure
6:33am
8-K
jo27x7iya2ani659gii
6 Nov 19
Regulation FD Disclosure
4:10pm
8-K
v8olg 8pgeom9z6
6 Nov 19
Aerie Pharmaceuticals Reports Third Quarter 2019
4:04pm
8-K
754bd92w
6 Nov 19
Regulation FD Disclosure
4:04pm
8-K
1xsu oseooqald
5 Nov 19
Aerie Pharmaceuticals Announces Positive Topline Results for Netarsudil Ophthalmic Solution in Phase 2 Study Conducted in Japan
6:40am
8-K
bnutj
24 Oct 19
Regulation FD Disclosure
6:43am
8-K
f3zwl2g 6z
10 Oct 19
Regulation FD Disclosure
4:02pm
8-K
3ucpf3a76sz3p bm7kp
2 Oct 19
Regulation FD Disclosure
7:05am
8-K
ter ellb7ct
20 Sep 19
Aerie Pharmaceuticals Receives Positive CHMP Opinion for Rhokiinsa® in the European Union
6:40am
8-K
dij514
19 Sep 19
Regulation FD Disclosure
6:44am
8-K
lsg9a9k6gxuws f2wy1
13 Sep 19
Entry into a Material Definitive Agreement
5:05pm
8-K
164h dl3tnb2oz
11 Sep 19
Other Events
6:10am
8-K
s8vgo72qydefwh lol
10 Sep 19
Entry into a Material Definitive Agreement
5:19pm
8-K
s0kjr7b50 968
10 Sep 19
Regulation FD Disclosure
6:32am
8-K
b8npvih77z l40ugas2
5 Sep 19
Regulation FD Disclosure
6:31am